<?xml version="1.0" encoding="UTF-8"?>
<p>Sarkar etÂ al. prepared benzothiazolyl quinoline derivatives by treatment of 2-aminobenzothiol with 2-hydroxy-benzaldehyde and studied their activities for the A1, A2A, A2B and A3 adenosine receptors. The A3 receptor is overexpressed in different cancer cell lines. The quinolone based derivative 
 <bold>48</bold> (
 <xref ref-type="fig" rid="F0029">Figure 29</xref>) showed the maximum potency for the hA3 adenosine receptor
 <xref rid="CIT0050" ref-type="bibr">
  <sup>50</sup>
 </xref>.
</p>
